Nomura Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Nomura Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.91M	Buy	22,200 +700	+3%	+$326K	0.03%	431
2025 Q4	$9.75M	Sell	21,500 -12,900	-38%	-$5.56M	0.01%	522
2025 Q3	$13.5M	Sell	34,400 -6,500	-16%	-$2.72M	0.02%	422
2025 Q2	$18.2M	Buy	40,900 +12,900	+46%	+$5.94M	0.04%	270
2025 Q1	$13.6M	Sell	28,000 -3,800	-12%	-$1.77M	0.03%	387
2024 Q4	$12.8M	Sell	31,800 -2,000	-6%	-$927K	0.02%	433
2024 Q3	$15.7M	Buy	33,800 +800	+2%	+$384K	0.04%	326
2024 Q2	$15.5M	Buy	33,000 +9,000	+38%	+$3.91M	0.03%	336
2024 Q1	$10M	Sell	24,000 -3,000	-11%	-$1.27M	0.03%	434
2023 Q4	$11M	Buy	+27,000	New	+$9.97M	0.03%	425
2023 Q3	–	Sell	-4,800	Closed	-$1.69M	–	1667
2023 Q2	$1.69M	Buy	+4,800	New	+$1.62M	﹤0.01%	758

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nomura Holdings's VRTX Position: Q1 2026 in Review

Nomura Holdings reduced its Vertex Pharmaceuticals (VRTX) stake by 45% in Q1 2026, selling an estimated $10.1M and leaving 26,101 shares worth $11.7M. The position accounts for 0.03% of the portfolio, ranked #388.

Nomura Holdings first reported a position in VRTX in Q2 2013 and has held it in 41 quarters since. The position peaked at $26.7M in Q3 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Nomura Holdings held 26,101 shares of Vertex Pharmaceuticals worth $11.7M as of Q1 2026.
Nomura Holdings sold 21,761 Vertex Pharmaceuticals shares in Q1 2026, an estimated $10.1M.
Vertex Pharmaceuticals made up 0.03% of Nomura Holdings's portfolio in Q1 2026, its #388 holding.
Nomura Holdings first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 41 quarters since.
Nomura Holdings's Vertex Pharmaceuticals position peaked at $26.7M in Q3 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.